AI
IMNM icon

Atom Investors’s Immunome IMNM Stock Holding History

Atom Investors’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.71M Buy
306,880
+131,113
+75% +$2.92M 0.48% 38
2025
Q4 		$3.78M Buy
+175,767
New +$3.08M 0.3% 115
2022
Q2 		– Sell
-39,770
Closed -$226K – 287
2022
Q1 		$226K Sell
39,770
-6,088
-13% -$45.5K 0.11% 161
2021
Q4 		$594K Buy
+45,858
New +$818K 0.1% 148

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Atom Investors's IMNM Position: Q1 2026 in Review

Atom Investors increased its Immunome (IMNM) stake by 75% in Q1 2026, buying an estimated $2.92M and bringing the position to 306,880 shares worth $6.71M. The position accounts for 0.48% of the portfolio, ranked #38.

Atom Investors first reported a position in IMNM in Q4 2021 and has held it in 4 quarters since. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • Atom Investors held 306,880 shares of Immunome worth $6.71M as of Q1 2026.
  • Atom Investors bought 131,113 Immunome shares in Q1 2026, an estimated $2.92M.
  • Immunome made up 0.48% of Atom Investors's portfolio in Q1 2026, its #38 holding.
  • Atom Investors first reported a position in Immunome in Q4 2021 and has held it in 4 quarters since.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Atom Investors's 13F filing for Q1 2026, filed 15 May 2026.